| article_id i : | 467 |
| pubmed_id i : | 10327433 |
| doi i : | 10.1016/S0893-133X(98)00107-9 |
| pdf_filename i : | Abi-Dargham_et_al_1999 |
| title i : | No evidence of altered in vivo benzodiazepine receptor binding in schizophrenia |
| citation i : | (1999) No evidence of altered in vivo benzodiazepine receptor binding in schizophrenia. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 10.1016/S0893-133X(98)00107-9 |
| include i : | 1 |
| independent i : | 1 |
| comments i : | No comments |
| status i : | 1 |
| creation_time i : | 2022-08-04 13:06:56 |
| modification_time i : | 2024-05-31 10:22:45 |
| created_by i : | joupes |
| modified_by i : | lihsun |
| contrast_id i : | 878 |
| contrast_name i : | Regional distribution Volumes in Schizophrenic Patients and compared with healthy Controls |
| article_id i : | 467 |
| modality i : | SPECT |
| target_molecule i : | GABA-A |
| tracer i : | [123I]iomazenil |
| model i : | Volume of distribution estimated with measured activities in ROI and plasma |
| include i : | 1 |
| independent i : | 1 |
| comments i : | |
| age_g1 i : | 45 |
| age_g1_males i : | 45 |
| age_g1_females i : | -1 |
| n_g1 i : | 16 |
| n_g1_males i : | 16 |
| n_g1_females i : | 0 |
| disorder_g1 i : | Healthy Controls |
| comorbidity_g1 i : | None |
| premedication_g1 i : | -1 |
| medicated_g1 i : | -1 |
| days_wo_drugs_g1 i : | -1 |
| smoking_g1 i : | -1 |
| age_g2 i : | 44 |
| age_g2_males i : | 44 |
| age_g2_females i : | -1 |
| n_g2 i : | 16 |
| n_g2_males i : | 16 |
| n_g2_females i : | 0 |
| disorder_g2 i : | Schizophrenia |
| comorbidity_g2 i : | 0 |
| premedication_g2 i : | neuroleptics, possibly benzodiazepine |
| medicated_g2 i : | 1 |
| days_wo_drugs_g2 i : | 0 |
| smoking_g2 i : | -1 |
| status i : | 1 |
| creation_time i : | 2022-08-04 13:10:07 |
| modification_time i : | 2024-05-31 10:22:37 |
| created_by i : | joupes |
| modified_by i : | lihsun |